Abdominal and gluteo-femoral markers of adiposity and risk of vascular-metabolic mortality in a prospective study of 150 000 Mexican adults

Abstract Aims Results of previous studies of abdominal adiposity and risk of vascular-metabolic mortality in Hispanic populations have been conflicting. We report results from a large prospective study of Mexican adults with high levels of abdominal adiposity. Methods and results A total of 159 755 adults aged ≥35 years from Mexico City were enrolled in a prospective study and followed for 16 years. Cox regression, adjusted for confounders, yielded mortality rate ratios (RRs) associated with three markers of abdominal adiposity (waist circumference, waist–hip ratio, and waist–height ratio) and one marker of gluteo-femoral adiposity (hip circumference) for cause-specific mortality before age 75 years. To reduce reverse causality, deaths in the first 5 years of follow-up and participants with diabetes or other prior chronic disease were excluded. Among 113 163 participants without prior disease and aged 35–74 years at recruitment, all adiposity markers were positively associated with vascular-metabolic mortality. Comparing the top versus bottom tenth of the sex-specific distributions, the vascular-metabolic mortality RRs at ages 40–74 years were 2.32 [95% confidence interval (CI) 1.84–2.94] for waist circumference, 2.22 (1.71–2.88) for the waist–hip ratio, 2.63 (2.06–3.36) for the waist–height ratio, and 1.58 (1.29–1.93) for hip circumference. The RRs corresponding to each standard deviation (SD) higher usual levels of these adiposity markers were 1.34 (95% CI 1.27–1.41), 1.31 (1.23–1.39), 1.38 (1.31–1.45), and 1.18 (1.13–1.24), respectively. For the markers of abdominal adiposity, the RRs did not change much after further adjustment for other adiposity markers, but for hip circumference the association was reversed; given body mass index and waist circumference, the RR for vascular-metabolic mortality for each one SD higher usual hip circumference was 0.80 (0.75–0.86). Conclusions In this study of Mexican adults, abdominal adiposity (and in particular the waist–height ratio) was strongly and positively associated with vascular-metabolic mortality. For a given amount of general and abdominal adiposity, however, higher hip circumference was associated with lower vascular-metabolic mortality.

[1]  G. Giannelli,et al.  Cross-sectional relationship among different anthropometric parameters and cardio-metabolic risk factors in a cohort of patients with overweight or obesity , 2020, PloS one.

[2]  Gretchen A. Stevens,et al.  World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions , 2019, The Lancet. Global health.

[3]  R. Collins,et al.  General and Abdominal Adiposity and Mortality in Mexico City , 2019, Annals of Internal Medicine.

[4]  R. Mägi,et al.  Causal relationships between obesity and the leading causes of death in women and men , 2019, PLoS genetics.

[5]  Y. Duarte,et al.  Body Composition Changes and 10-Year Mortality Risk in Older Brazilian Adults: Analysis of Prospective Data from the SABE Study. , 2019 .

[6]  K. Fontaine,et al.  Body Composition and Mortality in Mexican-American Adults: Results from the National Health and Nutrition Examination Survey , 2018, Obesity.

[7]  Eyal Oren,et al.  Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2017, Lancet.

[8]  Joshua A. Salomon,et al.  Health Effects of Overweight and Obesity in 195 Countries over 25 Years. , 2017, The New England journal of medicine.

[9]  R. Collins,et al.  Adiposity and Blood Pressure in 110 000 Mexican Adults , 2017, Hypertension.

[10]  F. Hu,et al.  Obesity , 2017, Nature Reviews Disease Primers.

[11]  R. Collins,et al.  Diabetes and Cause-Specific Mortality in Mexico City. , 2016, The New England journal of medicine.

[12]  H. Gerstein,et al.  BMI at Age 17 Years and Diabetes Mortality in Midlife: A Nationwide Cohort of 2.3 Million Adolescents , 2016, Diabetes Care.

[13]  G. Twig,et al.  Body-Mass Index in 2.3 Million Adolescents and Cardiovascular Death in Adulthood. , 2016, The New England journal of medicine.

[14]  E. Moriguchi,et al.  Overweight and abdominal obesity association with all-cause and cardiovascular mortality in the elderly aged 80 and over: A cohort study , 2016, The journal of nutrition, health & aging.

[15]  G. Danaei,et al.  Effects of body mass index, abdominal obesity, and type 2 diabetes on mortality in community-dwelling elderly in Sao Paulo, Brazil: analysis of prospective data from the SABE study. , 2015, The journals of gerontology. Series A, Biological sciences and medical sciences.

[16]  F. Karpe,et al.  Biology of upper-body and lower-body adipose tissue—link to whole-body phenotypes , 2015, Nature Reviews Endocrinology.

[17]  P. Schlattmann,et al.  General and abdominal obesity parameters and their combination in relation to mortality: a systematic review and meta-regression analysis , 2013, European Journal of Clinical Nutrition.

[18]  J. Danesh,et al.  Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies , 2011, The Lancet.

[19]  M. Thun,et al.  Waist circumference and all-cause mortality in a large US cohort. , 2010, Archives of internal medicine.

[20]  M. Schulze,et al.  General and abdominal adiposity and risk of death in Europe. , 2008, The New England journal of medicine.

[21]  N. Day,et al.  Serum lipid concentration in relation to anthropometric indices of central and peripheral fat distribution in 20,021 British men and women: results from the EPIC-Norfolk population-based cohort study. , 2006, Atherosclerosis.

[22]  Raymond J. Carroll,et al.  Measurement error in nonlinear models: a modern perspective , 2006 .

[23]  R. Collins,et al.  Cohort profile: the Mexico City Prospective Study. , 2006, International journal of epidemiology.

[24]  S. Yusuf,et al.  Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study , 2005, The Lancet.

[25]  Alan D. Lopez,et al.  Counting the dead and what they died from: an assessment of the global status of cause of death data. , 2005, Bulletin of the World Health Organization.

[26]  M. Plummer Improved estimates of floating absolute risk , 2004, Statistics in medicine.

[27]  R. Collins,et al.  Reliable measurement of glycated hemoglobin in frozen blood samples: implications for epidemiologic studies. , 2002, Clinical chemistry.

[28]  R. Collins,et al.  Blood pressure, stroke, and coronary heart disease Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias , 1990, The Lancet.

[29]  S. P. Akpabio World Health Organisation , 1983, British Dental Journal.